
Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK
Description
About Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK
The Human Glutamate decarboxylase 2 Peptide (IEDB: 25275) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Glutamate decarboxylase Peptide, H-IAFTSEHSHFSLK-OH (Uniprot: Q05329 aa: 274-286) from JPT is produced under strict quality control and quality management.
Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK - Specifications
- Peptide sequence: H-IAFTSEHSHFSLK-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Diabetes, Prediabetes, Rubella
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK
References:
Read References with JPT’s Antigen Peptides
Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK has been described in:
HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response., J Immunol, 1998 (PMID: 9743354)
Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein., J Immunol Methods, 2008 (PMID: 18353353)
Documentation
Documentation for Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK
Properties
Properties of Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Diabetes, Prediabetes, Rubella |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Glutamate decarboxylase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Glutamate decarboxylase 2 274-286, IAFTSEHSHFSLK
Information | Values |
---|---|
Sequence: | H-IAFTSEHSHFSLK-OH |
Specifications: | 13mer peptide as TFA salt |